These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 18466983)
1. A highly sensitive and reproducible HCV RNA hybridization method valuable for antiviral drug discovery. Zhao Y; Sanchez A; Nie X; Liu D; Hou X; Fabrycki J; Phadke A; Deshpande M; Huang M; Yang W J Virol Methods; 2008 Jul; 151(1):154-7. PubMed ID: 18466983 [TBL] [Abstract][Full Text] [Related]
2. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system. Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278 [TBL] [Abstract][Full Text] [Related]
3. Development of a cell-based assay for high-throughput screening of inhibitors against HCV genotypes 1a and 1b in a single well. Mondal R; Koev G; Pilot-Matias T; He Y; Ng T; Kati W; Molla A Antiviral Res; 2009 Apr; 82(1):82-8. PubMed ID: 19174175 [TBL] [Abstract][Full Text] [Related]
4. A novel, sensitive, and specific RT-PCR technique for quantitation of hepatitis C virus replication. Carrière M; Pène V; Breiman A; Conti F; Chouzenoux S; Meurs E; Andrieu M; Jaffray P; Grira L; Soubrane O; Sogni P; Calmus Y; Chaussade S; Rosenberg AR; Podevin P J Med Virol; 2007 Feb; 79(2):155-60. PubMed ID: 17177304 [TBL] [Abstract][Full Text] [Related]
5. [The direct antiviral effect of interferon-gamma on hepatitis C virus replicon]. Jia YT; Wei L; Jiang D; Cong X; Fei R Zhonghua Gan Zang Bing Za Zhi; 2006 Jan; 14(1):7-10. PubMed ID: 16420756 [TBL] [Abstract][Full Text] [Related]
6. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system. Hao W; Duggal R Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266 [TBL] [Abstract][Full Text] [Related]
8. Cellular models for the screening and development of anti-hepatitis C virus agents. Gondeau C; Pichard-Garcia L; Maurel P Pharmacol Ther; 2009 Oct; 124(1):1-22. PubMed ID: 19555718 [TBL] [Abstract][Full Text] [Related]
9. Replicons from genotype 1b HCV-positive sera exhibit diverse sensitivities to anti-HCV reagents. Nishimura G; Ikeda M; Mori K; Nakazawa T; Ariumi Y; Dansako H; Kato N Antiviral Res; 2009 Apr; 82(1):42-50. PubMed ID: 19428594 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha. Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339 [TBL] [Abstract][Full Text] [Related]
12. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication. Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantitative measurement of luciferase reporter activity and cell number in two- and three-dimensional cultures of hepatitis C virus replicons. Tonary AM; Pezacki JP Anal Biochem; 2006 Mar; 350(2):239-48. PubMed ID: 16480942 [TBL] [Abstract][Full Text] [Related]
14. 3-Amino-2(5H)furanones as inhibitors of subgenomic hepatitis C virus RNA replication. Iannazzo D; Piperno A; Romeo G; Romeo R; Chiacchio U; Rescifina A; Balestrieri E; Macchi B; Mastino A; Cortese R Bioorg Med Chem; 2008 Nov; 16(21):9610-5. PubMed ID: 18835180 [TBL] [Abstract][Full Text] [Related]
16. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside. Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121 [TBL] [Abstract][Full Text] [Related]
17. TAT peptides mediated small interfering RNA delivery to Huh-7 cells and efficiently inhibited hepatitis C virus RNA replication. Meng S; Wei B; Xu R; Zhang K; Wang L; Zhang R; Li J Intervirology; 2009; 52(3):135-40. PubMed ID: 19478527 [TBL] [Abstract][Full Text] [Related]
18. Development of a replicon-based phenotypic assay for assessing the drug susceptibilities of HCV NS3 protease genes from clinical isolates. Qi X; Bae A; Liu S; Yang H; Sun SC; Harris J; Delaney W; Miller M; Mo H Antiviral Res; 2009 Feb; 81(2):166-73. PubMed ID: 19063924 [TBL] [Abstract][Full Text] [Related]
19. A small-molecule probe for hepatitis C virus replication that blocks protein folding. Rakic B; Clarke J; Tremblay TL; Taylor J; Schreiber K; Nelson KM; Abrams SR; Pezacki JP Chem Biol; 2006 Oct; 13(10):1051-60. PubMed ID: 17052609 [TBL] [Abstract][Full Text] [Related]
20. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha. Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]